Co-Authors
This is a "connection" page, showing publications co-authored by Abdulkarim AbdulRahman and Manaf AlQahtani.
Connection Strength
5.570
-
COVID-19 viral load not associated with disease severity: findings from a retrospective cohort study. BMC Infect Dis. 2021 Jul 16; 21(1):688.
Score: 0.957
-
Is sickle cell disease a risk factor for severe COVID-19 outcomes in hospitalized patients? A multicenter national retrospective cohort study. EJHaem. 2021 Feb 10.
Score: 0.929
-
The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort. Infect Dis Ther. 2021 Mar; 10(1):439-455.
Score: 0.925
-
Quarantining arriving travelers in the era of COVID-19: balancing the risk and benefits a learning experience from Bahrain. Trop Dis Travel Med Vaccines. 2021 Jan 12; 7(1):1.
Score: 0.924
-
COVID-19 and sickle cell disease in Bahrain. Int J Infect Dis. 2020 Dec; 101:14-16.
Score: 0.904
-
Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease. Sci Rep. 2021 05 11; 11(1):9927.
Score: 0.236
-
Time Till Viral Clearance of Severe Acute Respiratory Syndrome Coronavirus 2 Is Similar for Asymptomatic and Non-critically Symptomatic Individuals. Front Med (Lausanne). 2021; 8:616927.
Score: 0.234
-
The effect of ABO blood group and antibody class on the risk of COVID-19 infection and severity of clinical outcomes. Sci Rep. 2021 03 11; 11(1):5745.
Score: 0.233
-
The prevalence of asymptomatic and symptomatic COVID-19 in a cohort of quarantined subjects. Int J Infect Dis. 2021 Jan; 102:285-288.
Score: 0.228